These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23045102)

  • 1. Local lymph node assays.
    Dearman RJ; Kimber I
    Curr Protoc Toxicol; 2004; Chapter 18():Unit18.2. PubMed ID: 23045102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The local lymph node assay (LLNA).
    Rovida C; Ryan C; Cinelli S; Basketter D; Dearman R; Kimber I
    Curr Protoc Toxicol; 2012 Feb; Chapter 20():Unit 20.7. PubMed ID: 22511117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine endpoints for the local lymph node assay: consideration of interferon-gamma and interleukin 12.
    Dearman RJ; Hilton J; Basketter DA; Kimber I
    J Appl Toxicol; 1999; 19(3):149-55. PubMed ID: 10362264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses.
    Basketter DA; Lea LJ; Dickens A; Briggs D; Pate I; Dearman RJ; Kimber I
    J Appl Toxicol; 1999; 19(4):261-6. PubMed ID: 10439340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local lymph node assay: validation assessment for regulatory purposes.
    Gerberick GF; Ryan CA; Kimber I; Dearman RJ; Lea LJ; Basketter DA
    Am J Contact Dermat; 2000 Mar; 11(1):3-18. PubMed ID: 10684384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local lymph node assay responses to paraphenylenediamine: intra- and inter-laboratory evaluations.
    Warbrick EV; Dearman RJ; Lea LJ; Basketter DA; Kimber I
    J Appl Toxicol; 1999; 19(4):255-60. PubMed ID: 10439339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local lymph node assay: differentiating allergic and irritant responses using flow cytometry.
    Gerberick GF; Cruse LW; Ryan CA
    Methods; 1999 Sep; 19(1):48-55. PubMed ID: 10525437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The local lymph node assay and potential application to the identification of drug allergens.
    Kimber I
    Toxicology; 2001 Feb; 158(1-2):59-64. PubMed ID: 11164993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
    J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of photoallergic potential in the local lymph node assay.
    Scholes EW; Basketter DA; Lovell WW; Sarll AE; Pendlington RU
    Photodermatol Photoimmunol Photomed; 1991 Dec; 8(6):249-54. PubMed ID: 1823150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
    Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
    Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between interleukin-6 production by contact allergen-activated draining lymph node cells and lymphoproliferative activity.
    Lappin MB; Dearman RJ; Norval M; Kimber I
    Am J Contact Dermat; 1998 Mar; 9(1):34-9. PubMed ID: 9471985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The local lymph node assay and skin sensitization testing.
    Kimber I; Dearman RJ
    Methods Mol Biol; 2010; 598():221-31. PubMed ID: 19967517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonradioisotopic endpoint for measurement of lymph node cell proliferation in a murine allergic contact dermatitis model, using bromodeoxyuridine immunohistochemistry.
    Lee JK; Park JH; Park SH; Kim HS; Oh HY
    J Pharmacol Toxicol Methods; 2002; 48(1):53-61. PubMed ID: 12750042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency and risk assessment of a skin-sensitizing disperse dye using the local lymph node assay.
    Betts CJ; Dearman RJ; Kimber I; Maibach HI
    Contact Dermatitis; 2005 May; 52(5):268-72. PubMed ID: 15899000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.